MEDIVEST INC
10QSB, 1997-11-14
DRUGS, PROPRIETARIES & DRUGGISTS' SUNDRIES
Previous: AMERICAN ENTERTAINMENT GROUP INC, 10QSB, 1997-11-14
Next: CSW CREDIT INC, 35-CERT, 1997-11-14





































                 U. S. Securities and Exchange Commission
                         Washington, D. C.  20549

                              FORM 10-QSB

[X]  QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES
     EXCHANGE ACT OF 1934

     For the quarter ended September 30, 1997
                           ------------------

[ ]  TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES
     EXCHANGE ACT OF 1934 

     For the transition period from               to
                                    -------------    -------------

                        Commission File No. 1-10077
                                            -------

                                MEDIVEST, INC.     
                                --------------
              (Name of Small Business Issuer in its Charter)

         UTAH                                            87-0401761
         ----                                            ----------         
(State or Other Jurisdiction of                     (I.R.S. Employer I.D. No.)
 incorporation or organization)

                            3646 West 2100 South
                        Salt Lake City, Utah  84120
                        ---------------------------    
                 (Address of Principal Executive Offices)

                Issuer's Telephone Number:  (801) 972-9090

                                    N/A
                                    ---      
       (Former Name or Former Address, if changed since last Report)

     Check whether the Issuer (1) filed all reports required to be filed by
Section 13 or 15(d) of the Exchange Act during the past 12 months (or for such
shorter period that the Company was required to file such reports), and (2)
has been subject to such filing requirements for the past 90 days.  

     (1)   Yes  X    No            (2)   Yes  X    No 
               ---      ---                  ---      ---

               (ISSUERS INVOLVED IN BANKRUPTCY PROCEEDINGS 
                       DURING THE PAST FIVE YEARS)

     Check whether the issuer has filed all documents and reports required to
be filed by Section 12, 13 or 15(d) of the Exchange Act after the distribution
of securities under a plan confirmed by a court.  Yes  X    No 
                                                      ---     ---
                   (APPLICABLE ONLY TO CORPORATE ISSUERS)

          State the number of shares outstanding of each of the Issuer's
classes of common equity, as of the latest practicable date:

                               September 30, 1997

                           Common - 1,356,556 shares

          
                    DOCUMENTS INCORPORATED BY REFERENCE

          A description of any "Documents Incorporated by Reference" is
contained in Item 6 of this Report.

Transitional Small Business Issuer Format   Yes  X   No 
                                                ---     ---

                  PART I - FINANCIAL INFORMATION

Item 1.   Financial Statements.

          The Consolidated Financial Statements of the Company required
to be filed with this 10-QSB Quarterly Report were prepared by management and
commence on the following page, together with related Notes.  In the opinion
of management, the Consolidated Financial Statements fairly present the
financial condition of the Company.

<TABLE>

                         MEDIVEST, INC. 
                  (A Development Stage Company)
                         BALANCE SHEETS 
<CAPTION>

                                                (Unaudited)
                                                September 30,  December 31,
                                                    1997             1996   
<S>                                               <C>          <C>
Assets
    Cash and Cash Equivalents                     $        -   $   23,425
    Prepaid Assets                                     4,397       17,587

Total Assets                                      $    4,397   $   41,012

Liabilities and Stockholders' Equity 
  Liabilities 
    Accounts Payable                              $   11,996   $   11,062
    Income Tax Payable                                     -          100
    Note Payable                                      35,000       35,000
    Other Liabilities                                      -      159,231

     Total Liabilities                                46,996      205,393

  Stockholders' Equity    
    Common Stock to be issued                            135   -
    Common Stock, authorized
      50,000,000 shares of
      $.001 par value, issued
      and outstanding 1,356,556
      as of September 30, 1997, 
      650,287 in 1996                                  1,357          650
 
    Additional Paid in Capital                     1,616,494    1,608,111
    Previous Retained Deficit                     (1,867,999)  (1,867,999)
    Earnings(Deficit)Accumulated 
      During Development Stage                       207,414       94,857

     Total Stockholders' Equity                      (42,599)    (164,381)

Total Liabilities and Stockholders' 
  Equity                                           $   4,397   $   41,012
</TABLE>
The accompanying notes are an integral part of these financial statements.
<TABLE>                                
                         MEDIVEST, INC. 
                  (A Development Stage Company)
                    STATEMENTS OF OPERATIONS 
                           (Unaudited)
 <CAPTION>

                                                                   Cumulative
                                                                      Since
                                                                    Inception
                                                                        of
                          For the Three Months For the Nine Months Development
                              September 30,           September 30,
                              1997     1996          1997     1996     Stage   
<S>                      <C>         <C>         <C>        <C>      <C>
Revenues

     Total Revenue        $      -    $     -     $     -   $     -       -
 
Expenses 
 
  General & Administrative (15,852)    (1,750)    (30,622)    (1,750) (48,015)
 
     Total Expenses         (15,852)   (1,750)    (30,622)    (1,750) (48,015)
              
Net Loss Before and Taxes
  Extraordinary Item        (15,852)   (1,750)    (30,622)     (1,750)(48,015)
Net Taxes                         -         -           -           -    (100)

Net Loss Before
  Extraordinary Item        (15,852)   (1,750)    (30,622)     (1,750)(48,115)

Extraordinary Item - 
  gain on restructuring
  of debt, Net of Taxes           -         -      143,179           - 255,529

Net Income (Loss)         $ (15,852) $ (1,750)    $112,557    $(1,750)$207,414

Net Earnings (Loss) 
   Per Share              $    (.02) $      -     $    .17    $     -

Weighted Average 
   Shares Outstanding       676,000   500,287      655,362    500,287
</TABLE>

The accompanying notes are an integral part of these financial statements.
<TABLE>
                             MEDIVEST, INC. 
                      (A Development Stage Company)
                        STATEMENTS OF CASH FLOWS 
                               (Unaudited)
<CAPTION>
                                                                   Cumulative  
                                                                      Since
                                                                    Inception
                                       For the Nine Months Ended       of
                                             September 30,         Development
                                          1997           1996         Stage    
<S>                                    <C>           <C>         <C>
Cash Flows From Operating
Net Income (Loss)                      $   112,556    $ (1,750)  $ 207,414

Adjustments to reconcile net income
to net cash provided by operating
activities:
 Common Stock in Exchange for Services       7,000           -       7,000
Changes in Assets and Liabilities 
  (Increase)Decrease in
    Prepaid Finance Charge                  13,191           -      (4,397)
  Increase (decrease) in Accounts
    Payable                                  2,291       1,750      13,353
  Decrease in Other Liabilities           (158,363)                      -     
      (275,957)         
  Increase(Decrease) in Taxes Payable         (100)                      -     
             -

Net Cash Used by Operating Activities      (23,425)                      -     
       (52,587)

Cash Flows From Investing Activities             -           -           -

Cash Flows From Financing Activities
  Proceeds from Note 
    Payable                                      -           -      35,000
  Proceeds from the Sale
    of Common Stock                              -           -      17,587

Net Cash Provided by Financing
    Activities                                   -           -      52,587

Net Increase (Decrease) in Cash 
    and Cash Equivalents                   (23,425)          -           -

Cash and Cash Equivalents at 
    Beginning of Year                       23,425           -           -
    
Cash and Cash Equivalents at
    End of Period                      $         - $         -$          -
</TABLE>
Supplemental Disclosure of Non-Cash Investing and Financing Activities
On February 21, 1997 the Company issued 6,269 shares of stock in satisfaction
of other liabilities of $868.

On September 3, 1997, the Company entered into a Common Stock for compensation
agreement in satisfaction of a portion of the accounts payable.

The accompanying notes are an integral part of these financial statements.
                                    
                         MEDIVEST, INC. 
                  (A Development Stage Company)
                NOTES TO THE FINANCIAL STATEMENTS 
          For the Nine Months Ended September 30, 1997 
                          (Unaudited)


NOTE 1 - Interim Reporting 

     The accompanying unaudited financial statements have been
prepared in accordance with generally accepted accounting
principles and with Form 10-QSB requirements.  Accordingly, they do
not include all of the information and footnotes required by
generally accepted accounting principles for complete financial
statements.  In the opinion of management, all adjustments
considered necessary for a fair presentation have been included. 
Operating results for the nine month period ended September 30,
1997, are not necessarily indicative of the results that may be
expected for the year ended December 31, 1997.

NOTE 2 - Common Stock

     On September 5, 1997, the Company issued 700,000 shares of
common stock in exchange for consulting services rendered.  Also,
effective as of September 5, 1997, the Company has entered into an
agreement to issue 135,656 shares of common stock in lieu of
compensation for consulting and legal services rendered.  The cost
of the services has been charged to operations, and additional
paid-in capital has been increased by $7,521, representing the
excess of the cost of the services over the par value of the common
stock issued.

Item 2.   Management's Discussion and Analysis or Plan of Operation.

Plan of Operation.

      The Company has not engaged in any material operations or
had any revenues from operations during the last two calendar years. The
Company's plan of operation for the next 12 months is to continue to seek the
acquisition of assets, properties or businesses that may benefit the Company
and its stockholders. Management anticipates that to achieve any such
acquisition, the Company will issue shares of its common stock as
the sole consideration for any such acquisition.

     During the next 12 months, the Company's only foreseeable
cash requirements will relate to maintaining the Company in good
standing or the payment of expenses associated with reviewing or
investigating any potential business venture.  Such funds may
be advanced by management or stockholders as loans to the Company.  Because
the Company has not identified any such venture as of the date of this Report,
it is impossible to predict the amount of any such loans or advances. 
However, any such loans or advances should not exceed $25,000 and will be on
terms no less favorable to the Company than would be available from a
commercial lender in an arm's length transaction.   As of the date of this
Report, the Company is not involved in any negotiations respecting any such
venture.  

Results of Operations.
- ----------------------

     Other than restoring and maintaining its good corporate 
standing in the State of Utah, compromising and settling its 
debts and seeking the acquisition of assets, properties or 
businesses that may benefit the Company and its stockholders, 
the Company has had no material business operations during the two 
most recent calendar years.

     During the quarters ended September 30, 1997 and 1996, the Company had no
business operations, but compromised substantial debt for nominal payments
resulting in a net loss of $15,852, and a decrease of liabilities reflected
at December 31, 1996, from $205,393 to $46,996 at September 30, 1997.

Liquidity.
- ---------

     During the fourth quarter of 1996, the Company obtained a loan from a
non-affiliated party in the amount of $35,000, which funds were utilized to
compromise outstanding liabilities at approximately ten cents on the dollar.



                   PART II - OTHER INFORMATION

Item 1.   Legal Proceedings.

          None; not applicable.

Item 2.   Changes in Securities.

          None; not applicable.

Item 3.   Defaults Upon Senior Securities.

          None; not applicable.

Item 4.   Submission of Matters to a Vote of Security Holders.

          No matter was submitted to a vote of the Company's security holders
during the second quarter of the calendar year covered by this Report or
during the two previous calendar years.

Item 5.   Other Information.

           On September 5, 1997, the Company authorized the issuance of
700,000  unregistered  and  restricted  shares of its $0.001 par value common
stock to two of its executive officers and directors, 350,000 shares to each,
for services rendered and valued at $3,500 each (these shares are included in
the present number of outstanding shares of common stock of the Company
indicated in this Report); and also adopted a written compensation agreement
pursuant to which counsel for the Company will be partially compensated for
the services they have rendered to date; provided, however, that the aggregate
total of the shares to be issued under the written compensation agreement
shall not exceed 10% of the outstanding securities of the Company, or
approximately 130,000 shares.  The agreement was to issue 135,656 shares of
common stock in lieu of compensation for consulting and legal services
rendered.  The cost of the services has been charged to operations, and
additional paid-in capital has been increased by $7,521, representing the
excess of the cost of the services over the par value of the common stock
issued.

           On September 7, 1997, 55,251 shares which had been issued and were
not fully paid were delivered to the Company for cancellation.  The Company
intends to bring legal action against two other stockholders seeking to cancel
an additional 110,502 shares of common stock of the Company which management
believes were issued for no consideration.  These shares are included in the
present number of outstanding shares of common stock of the Company indicated
in this Report.

Item 6.   Exhibits and Reports on Form 8-K.
                                                        Page
          (a)  Exhibits.*                               Number
               
               None.

          (b)  Reports on Form 8-K.

               None.

      *   A summary of any Exhibit is modified in its entirety by reference
          to the actual Exhibit.


                            SIGNATURES

          Pursuant to the requirements of the Securities Exchange Act of
1934, the Registrant has duly caused this Report to be signed on its behalf by
the undersigned thereunto duly authorized.

                                       MEDIVEST, INC.



Date: 11/12/97                         By/s/John M. Williams  
      ----------                        -------------------------------------- 
                                        John M. Williams
                                        President, Vice President and Director



          Pursuant to the requirements of the Securities Exchange Act of 1934,
as amended, this Report has been signed below by the following persons on
behalf of the Company and in the capacities and on the dates indicated:


                                        MEDIVEST, INC.




Date: 11/12/97                           By/s/John M. Williams   
     ----------                          ------------------------------------
                                         John M. Williams
                                          President, Vice President and        
                                         Director
                                         

Date: 11/12/97                           By/s/William R. Stoddard   
     ----------                          ------------------------------------
                                         William R. Stoddard
                                         Secretary/Treasurer and Director

<TABLE> <S> <C>

<ARTICLE> 5
       
<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-1997
<PERIOD-END>                               SEP-30-1997
<CASH>                                            4397
<SECURITIES>                                         0
<RECEIVABLES>                                        0
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                                     0
<PP&E>                                               0
<DEPRECIATION>                                       0
<TOTAL-ASSETS>                                    4397
<CURRENT-LIABILITIES>                            46996
<BONDS>                                              0
                                0
                                          0
<COMMON>                                          1357
<OTHER-SE>                                     (251505)
<TOTAL-LIABILITY-AND-EQUITY>                      4397
<SALES>                                              0
<TOTAL-REVENUES>                                     0
<CGS>                                                0
<TOTAL-COSTS>                                        0
<OTHER-EXPENSES>                                 30622
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                                 (30622)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                                  0
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                 143179
<CHANGES>                                            0
<NET-INCOME>                                    112557
<EPS-PRIMARY>                                      .17
<EPS-DILUTED>                                        0
        

</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission